European Society of Gene and Cell Therapy is pleased to continue its partnership with Mary Ann Liebert, Inc.,
publishers of Human Gene Therapy
As the Official Journal of ESGCT since September 1, 2007, new and renewing members receive very
favorable subscription rates to Human Gene Therapy and are eligible for free online access. The Journal publishes the abstract book for the annual ESGCT meeting.
Human Gene Therapy has been named in "DBIO 100"
One of the 100 Most Influential Journals in Biology & Medicine over the last 100 years as voted by the BioMedical & Life Sciences Division of the Special Libraries Association on the occasion of its Centennial.
Latest Impact Factor* is 4.104 - * 2008 Journal Citation Reports® published by Thomson Reuters, 2009
In addition, all members of ESGCT are given the option to receive Genetic Engineering & Biotechnology News on a complimentary basis by filling out a simple qualification form. Additional information is sent to all members via email.
Human Gene Therapy Editor-in-Chief James M. Wilson, MD, PhD welcomes your manuscript submissions. All accepted papers are published online ahead of print.
The current issue of the Human Gene Therapy journal is available free online.